Thalys Medical Technology Group Inc
SSE:603716
Wall Street
Price Targets
Price Targets Summary
Thalys Medical Technology Group Inc
Price Targets
Revenue
Forecast
Revenue Estimate
Thalys Medical Technology Group Inc
For the last 8 years the compound annual growth rate for Thalys Medical Technology Group Inc's revenue is 23%. The projected CAGR for the next 5 years is -18%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Thalys Medical Technology Group Inc's stock price target?
Not Available
Thalys Medical Technology Group Inc doesn't have any price targets made by Wall Street professionals.
What is Thalys Medical Technology Group Inc's Revenue forecast?
Projected CAGR
-18%
For the last 8 years the compound annual growth rate for Thalys Medical Technology Group Inc's revenue is 23%. The projected CAGR for the next 5 years is -18%.